Connect On WhatsApp
18001200365
/
+91-9654860915
For Careers:
+91-9220822566
Menu
Menu
+91-9654860915
Select your language
Eng
Menu
Home
Company
Partners
Services
Named Patient Management
Clinical Trial Sourcing
Indian Generic Medicines
Real World Data
Our Products
Triokris
News
Contact
Ikris Health+ App
Newsletter ( Coming Soon )
Careers
Resources
Home >>
FDA News >>
FDA Approves Orzeyful (Oveporexton)
FDA Approves Orzeyful (Oveporexton)
FDA Approves Orzeyful (Oveporexton) for Narcolepsy Type 1 Symptoms
Contact Us
Loading...
Submit
Published Date:
17-08-2026
Written By:
Nitin Goswami
Share
LinkedIn
Twitter
Facebook
Instagram